HHS Will Buy More Paxlovid, Offer Free Access During Commercialization, Drug-Pricing Advocate Wary

By Maaisha Osman / October 16, 2023 at 1:02 PM

HHS has agreed to buy more Paxlovid so it can continue providing Medicare, Medicaid and uninsured individuals free access after the COVID-19 antiviral soon transitions to the commercial market, but a consumer advocate notes the government hasn’t disclosed how much it will pay for the new product and the agreement doesn’t prevent Pfizer hiking commercial prices.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.